Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
1,270
mentions
- News 878
- X 280
- Blogs 72
- Facebook 33
- +2 more

